1. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research andexpert opinion of a broad international panel of rheumatologists in the 3E Initiative. Visser K1, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW,Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Murphy G,Østergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, DougadosAnn Rheum Dis. 2009 Jul;68(7):1086-93. doi: 10.1136/ard.2008.094474. Epub 2008 Nov 25.

2. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis Gorter SL1, Bijlsma JW, Cutolo M, Gomez- Reino J, Kouloumas M, Smolen JS, Landewé R.Ann Rheum Dis. 2010 Jun;69(6):1010-4. doi: 10.1136/ard.2009.127332. Epub 2010 May 6.

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Smolen JS1, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D. Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25

4. Recommendations for screening and detection of connective- tissue disease associated pulmonary arterial hypertension. Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, Hachulla E, Humbert M, Langleben D, Mathai SC, Saggar R, Visovatti S, Altorok N, Townsend W, Fitzgerald J, McLaughlin V. Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38172. [Epub ahead of print] 5. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis . Jérôme Avouac, Dörte Huscher, Daniel E Furst, Christian F Opitz, Oliver Distler, Yannick Allanore, for the EPOSS group Ann Rheum Dis doi:10.1136/annrheumdis-2012-202567. Published Online First 24 January 2013

6. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Marmor MF1, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of Ophthalmology. Ophthalmology. 2011 Feb;118(2):415-22. doi: 10.1016/j.ophtha.2010.11.017.

7. Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Morganroth PA1, Kreider ME, Okawa J, Taylor L, Werth VP. Arch Dermatol. 2010 Jul;146(7):729-38. doi: 10.1001/archdermatol.2010.134.

8. Evidence-Based Guidelines for the Use of Immunologic Tests: Antinuclear Antibody Testing Daniel H. Solomon,1 Arthur J. Kavanaugh,2 Peter H. Schur,1 and the American College of Rheumatology ad hoc committee on immunologic testing guidelines Arthritis & Rheumatism (Arthritis Care & Research) Vol. 47, No. 4, August 15, 2002, pp 434–444

9. National Institute for Health and Care Excellence Rheumatoid arthritis The management of rheumatoid arthritis in adults Issued: February 2009 last modified: August 2013 NICE clinical guideline 79 guidance.nice.org.uk/cg79

10.Guidelines for Clinical Use of the Antinuclear Antibody Test and Tests for Specific Autoantibodies to Nuclear Antigens Arthur Kavanaugh, MD; Russell Tomar, MD; John Reveille, MD; Daniel H. Solomon, MD, MPH; Henry A. Homburger, MD Arch Pathol Lab Med—Vol 124, January 2000

11.Guidelines for the Laboratory Use of Autoantibody Tests in the Diagnosis and Monitoring of Autoimmune Rheumatic Diseases Renato Tozzoli, MD,1 Nicola Bizzaro, MD,2 Elio Tonutti, MD,3 Danilo Villalta, MD,4 Danila Bassetti, MD,5 Fabio Manoni, MD,6 Anna Piazza, MD,7 Marco Pradella, MD,8 and Paolo Rizzotti, MD9 Am J Clin Pathol 2002;117:316-324

12.Long-term management of patients taking immunosuppressive drugs Denise C Hsu, Constance H Katelaris, Australian prescriber Volume 32 | NUM BER 3 | JUNE 2009

13.Rheumatoid Arthritis: Diagnosis Management and Monitoring British Columbia Ministry of Health BCCGuidlines.ca Effective Date: September 30, 2012

14.Assessing, managing and monitoring biologic therapies for inflammatory arthritis Guidance for rheumatology practitioners An advisory document prepared by the Royal College of Nursing Rheumatology BiologicsWorking Party, in conjunction with other members of the ArthritisMusculoskeletal Alliance October 2009, second edition

15.Perspectives in lupus nephritis The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus Renato Alberto Sinico, Bruna Bollini, Ettore Sabadini, Luca Di Toma, Antonella Radice - Nephrology and Dialysis Unit and Center of Clinical Immunology and Rheumatology, San Carlo Borromeo Hospital, Milan - Italy J NEPHROL 2002; 15 (suppl. 6): S20-S27

16.Recommendations for the use of biologic agents for the treatment of rheumatic diseases Australian Rheumatology Association Mona Manghani, Kathie Tymms, Claire Barrett, Therapeutics Committee, Australian Rheumatology Association Revised 6 January 2011